Feasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ Treatment

Exclusion Criteria

• •Known sensitivity to lidocaine or any other anesthetic of the amide type.
• •History of anaphylactic shock.
• •Presence of an active systemic or local skin disease that may affect wound healing.
• •Current therapy with class I antiarrhythmic drugs (e.g., tocainide, mexiletine).
• •Known or suspected hypersensitivity to LMX-4 active substance, or any of the amide-type local anaesthetics, or any of the excipients (protocol section 10.3).
• •Severe solar elastosis.
• •Excessive subcutaneous fat in the face and neck.
• •Body mass index of 30 or greater.
• •Excessive skin laxity on the face and neck.
• •Significant scarring in areas to be treated.
• •Significant open facial wounds or lesions.
• •Severe or cystic acne on the face.
• •Presence of a metal stent or implant in the facial area to be treated.